Global Information
회사소개 | 문의 | 위시리스트

트립토렐린 시장 : 규모, 점유율, 동향, 예측(-2026년)

Triptorelin Market - Size, Share, Trends, and Forecast to 2026

리서치사 Coherent Market Insights
발행일 2018년 07월 상품 코드 785775
페이지 정보 영문
가격
US $ 4,500 ₩ 5,479,000 PPT Turned PDF (Single User License)
US $ 7,000 ₩ 8,523,000 PPT Turned PDF (Multi-user License)
US $ 10,000 ₩ 12,176,000 PPT Turned PDF (Enterprise User License)


트립토렐린 시장 : 규모, 점유율, 동향, 예측(-2026년) Triptorelin Market - Size, Share, Trends, and Forecast to 2026
발행일 : 2018년 07월 페이지 정보 : 영문

트립토렐린 시장은 전립선암 및 침샘암 이환율 상승 및 중추성 사춘기 조발증(성조숙증) 유병률의 세계적인 상승 등에 의해 2026년까지 높은 성장률을 이룰 것으로 예상되고 있습니다.

세계의 트립토렐린(Triptorelin) 시장을 조사했으며, 시장 개요, 의약품 종류·용도·유통채널·지역별 시장 규모 추이와 예측, 시장 성장 촉진요인 및 저해요인 분석, 경쟁 구도, 주요 기업 개요 등의 정보를 제공합니다.

목차

제1장 조사 목적과 전제조건

  • 조사 목적
  • 전제조건
  • 약어

제2장 시장 개요

  • 보고서 개요
    • 시장 정의와 범위
  • 주요 요약
    • 시장 개요 : 의약품 종류별
    • 시장 개요 : 용도별
    • 시장 개요 : 유통채널별
    • 시장 개요 : 지역별
  • Coherent Opportunity Map(COM)

제3장 시장 역학, 규제, 동향 분석

  • 시장 역학
    • 성장 촉진요인
    • 성장 저해요인
    • 시장 기회
  • 규제 시나리오
  • 시장 동향
  • 역학
  • 신제품 승인/발매
  • 합병/인수
  • 전략적 제휴
  • PEST 분석

제4장 세계의 트립토렐린 시장 : 의약품 종류별

  • 서론
  • Triptorelin pamoate
  • Triptorelin aceta
  • Triptorelin embonate

제5장 세계의 트립토렐린 시장 : 용도별

  • 서론
  • 전립선암
  • 근치적 전립선 적제술
  • 자궁내막증
  • 침샘암
  • 중추성 사춘기 조발증

제6장 세계의 트립토렐린 시장 : 유통경로별

  • 서론
  • 병원 약국
  • 소매 약국
  • 온라인 약국

제7장 세계의 트립토렐린 시장 : 지역별

  • 서론
  • 북미
    • 미국
    • 캐나다
  • 유럽
    • 영국
    • 독일
    • 이탈리아
    • 프랑스
    • 스페인
    • 러시아
    • 기타
  • 아시아태평양
    • 중국
    • 일본
    • 인도
    • ASEAN 국가
    • 호주
    • 한국
    • 기타
  • 라틴아메리카
    • 브라질
    • 멕시코
    • 아르헨티나
    • 기타
  • 중동
    • 걸프협력회의(GCC)
    • 이스라엘
    • 기타
  • 아프리카
    • 북아프리카
    • 중앙아프리카
    • 남부아프리카

제8장 경쟁 환경

  • 히트 맵 해석
  • 기업 개요
    • Ipsen
    • Bachem
    • Ferring Pharmaceuticals Pvt Ltd.
    • Chengdu Tiantaishan pharmaceutical Co., Ltd.
    • Tecnofarma
    • Dr. Reddy's Laboratories Ltd.
    • Teva Pharmaceutical Industries Ltd.(Actavis Specialty Pharmaceuticals Co.)
    • Debiopharm Group
    • Arbor Pharmaceuticals, LLC
  • 애널리스트의 견해

제9장 섹션

  • 참고 문헌
  • 애널리스트의 견해
  • 조사 방법
  • Coherent Market Insights에 대해
LSH 19.03.04

Triptorelin is a peptide formulation for injection that was developed mainly for the treatment of advanced metastatic prostate cancer. Furthermore, other indications developed subsequently include the treatment of uterine fibroids (a benign tumor of muscle tissues in the uterus), endometriosis (proliferation of endometrial tissue, the mucous membrane that lines the uterine wall outside the reproductive tract) prior to surgery or when surgery is not deemed appropriate, as well as early onset puberty and female infertility (in vitro fertilization). Other modalities of triptorelin such as triptorelin acetate, triptorelin pamoate and triptorelin embonate are also used for prostate cancer treatment.

Market Dynamics

Triptorelin market is expected to witness lucrative growth opportunities during forecast period, owing to increasing incidence of prostate cancer and salivary gland cancer and increasing prevalence of central precocious puberty among the young patients below age eight and nine years, worldwide. For instance, according to National Organization for Rare Disorders (NORD), 2016 data findings, Central Precocious Puberty (CPP), accounted for 1 to 5 in 10,000 children with a female to male ratio of about 20:1, in U.S.

In March 2017, Medicines and Healthcare Products Regulatory Agency (MHRA) in the UK, in coordination with fourteen other European regulatory agencies approved a new indication of Decapeptyl (triptorelin). According to these new indication, Decapeptyl (triptorelin) will be used as adjuvant treatment in combination with tamoxifen or aromatase inhibitor for endocrine-responsive early-stage breast cancer in women at high-risk of recurrence who are confirmed as pre-menopausal after completion of chemotherapy. This would enhance the revenue for growth for triptorelin market, during forecast period.

Furthermore, higher efficacy and tolerability of triptorelin in suppression of gonadotropin secretion in prostate cancer and precocious puberty is increasing adoption of triptorelin in the market.

Key features of the study:

This report provides in-depth analysis of triptorelin market and provides market size (US$ Million) and Compound Annual Growth Rate (CAGR %) for the forecast period (2018 – 2026), considering 2017, as the base year

It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players

It profiles leading players in the global triptorelin market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies and future plans

Key companies covered as a part of this study include Ipsen, Bachem, Ferring Pharmaceuticals Pvt Ltd., Chengdu Tiantaishan pharmaceutical Co., Ltd., Tecnofarma, Dr. Reddy’s Laboratories Ltd., Teva Pharmaceutical Industries Ltd. (Actavis Specialty Pharmaceuticals Co.), Debiopharm Group, and Arbor Pharmaceuticals, LLC.

Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics

The global triptorelin market report caters to various stakeholders in this industry including investors, suppliers, triptorelin based product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the triptorelin market.

Detailed Segmentation:

  • Global Triptorelin Market, By Drug Type:
  • Triptorelin Pamoate
  • Triptorelin Acetate
  • Triptorelin Embonate
  • Global Triptorelin Market, By Application:
  • Prostate Cancer
  • Radical Prostatectomy
  • Endometriosis
  • Salivary Gland Cancer
  • Central Precocious Puberty
  • Global Triptorelin Market, By Distribution Channel:
  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
  • Global Triptorelin Market, By Geography:
  • North America
  • By Country:
  • U.S.
  • Canada
  • By Drug Type:
  • Decapeptyl SR
  • Trelstar
  • Decapeptyl SR
  • Gonapeptyl depot
  • Salvacyl
  • Triptorelin pamoate
  • Triptorelin acetate
  • Triptorelin embonate
  • By Application
  • Prostate Cancer
  • Radical Prostatectomy
  • Endometriosis
  • Salivary Gland Cancer
  • Central Precocious Puberty
  • By Distribution Channel:
  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
  • Europe
  • By Country:
  • Germany
  • France
  • Italy
  • UK
  • Spain
  • Russia
  • Rest of Europe
  • By Drug Type:
  • Triptorelin pamoate
  • Decapeptyl SR
  • Trelstar
  • Triptorelin acetate
  • Decapeptyl SR
  • Gonapeptyl depot
  • Triptorelin embonate
  • Salvacyl
  • By Application
  • Prostate Cancer
  • Radical Prostatectomy
  • Endometriosis
  • Salivary Gland Cancer
  • Central Precocious Puberty
  • By Distribution Channel:
  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
  • Asia Pacific
  • By Country:
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Rest of Asia Pacific
  • By Drug Type:
  • Triptorelin pamoate
  • Decapeptyl SR
  • Trelstar
  • Triptorelin acetate
  • Decapeptyl SR
  • Gonapeptyl depot
  • Triptorelin embonate
  • Salvacyl
  • By Application
  • Prostate Cancer
  • Radical Prostatectomy
  • Endometriosis
  • Salivary Gland Cancer
  • Central Precocious Puberty
  • By Distribution Channel:
  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
  • Middle East
  • By Country:
  • GCC
  • Israel
  • Rest of Middle East
  • By Drug Type:
  • Triptorelin pamoate
  • Decapeptyl SR
  • Trelstar
  • Triptorelin acetate
  • Decapeptyl SR
  • Gonapeptyl depot
  • Triptorelin embonate
  • Salvacyl
  • By Application
  • Prostate Cancer
  • Radical Prostatectomy
  • Endometriosis
  • Salivary Gland Cancer
  • Central Precocious Puberty
  • By Distribution Channel:
  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
  • Latin America
  • By Country:
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • By Drug Type:
  • Triptorelin pamoate
  • Decapeptyl SR
  • Trelstar
  • Triptorelin acetate
  • Decapeptyl SR
  • Gonapeptyl depot
  • Triptorelin embonate
  • Salvacyl
  • By Application
  • Prostate Cancer
  • Radical Prostatectomy
  • Endometriosis
  • Salivary Gland Cancer
  • Central Precocious Puberty
  • By Distribution Channel:
  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
  • Africa
  • By Country:
  • South Africa
  • Central Africa
  • North Africa
  • By Drug Type:
  • Triptorelin pamoate
  • Decapeptyl SR
  • Trelstar
  • Triptorelin acetate
  • Decapeptyl SR
  • Gonapeptyl depot
  • Triptorelin embonate
  • Salvacyl
  • By Application
  • Prostate Cancer
  • Radical Prostatectomy
  • Endometriosis
  • Salivary Gland Cancer
  • Central Precocious Puberty
  • By Distribution Channel:
  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
  • Company Profiles
  • Ipsen *
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments
  • Strategies
  • Bachem
  • Ferring Pharmaceuticals Pvt Ltd.
  • Chengdu Tiantaishan pharmaceutical Co., Ltd.
  • Tecnofarma
  • Reddy’s Laboratories Ltd.
  • Teva Pharmaceutical Industries Ltd. (Actavis Specialty Pharmaceuticals Co.)
  • Debiopharm Group
  • Arbor Pharmaceuticals, LLC
  • “*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objective and Assumption

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Overview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Drug Type
    • Market Snippet, By Application
    • Market Snippet, By Distribution Channel
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Regulatory Scenario
  • Market Trends
  • Epidemiology
  • New Product Approvals/Launch
  • Mergers/ Acquisition
  • Strategic Collaborations
  • PEST Analysis

4. Global Triptorelin Market, By Drug Type, 2016 - 2026 (US$ Million)

  • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017 - 2026
    • Segment Trends
  • Triptorelin pamoate
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Triptorelin acetate
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Triptorelin embonate
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)

5. Global Triptorelin Market, By Application, 2016 - 2026 (US$ Million)

  • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017 - 2026
    • Segment Trends
  • Prostate Cancer
    • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017 - 2026
  • Radical Prostatectomy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Endometriosis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Salivary Gland Cancer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Central Precocious Puberty
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)

6. Global Triptorelin Market, By Distribution Channel, 2016 - 2026 (US$ Million)

  • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017 - 2026
    • Segment Trends
  • Hospital Pharmacy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Retail Pharmacy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Online Pharmacy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)

7. Global Triptorelin Market, By Regions, 2016 - 2026 (US$ Million)

  • Introduction
    • Market Share Analysis, By Region, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, For Regions, 2017 - 2026
  • North America
    • Market Size and Forecast, By Drug Type, 2016 - 2026 (US$ Million)
    • Market Size and Forecast, By Application, 2016 - 2026 (US$ Million)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2026 (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
  • U.S.
  • Canada
  • Europe
    • Market Size and Forecast, By Drug Type, 2016 - 2026 (US$ Million)
    • Market Size and Forecast, By Application, 2016 - 2026 (US$ Million)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2026 (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Drug Type, 2016 - 2026 (US$ Million)
    • Market Size and Forecast, By Application, 2016 - 2026 (US$ Million)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2026 (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
  • China
  • Japan
  • India
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
    • Market Size and Forecast, By Drug Type, 2016 - 2026 (US$ Million)
    • Market Size and Forecast, By Application, 2016 - 2026 (US$ Million)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2026 (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Africa
    • Market Size and Forecast, By Drug Type, 2016 - 2026 (US$ Million)
    • Market Size and Forecast, By Application, 2016 - 2026 (US$ Million)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2026 (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
  • North Africa
  • Central Africa
  • South Africa
  • Middle East
    • Market Size and Forecast, By Drug Type, 2016 - 2026 (US$ Million)
    • Market Size and Forecast, By Application, 2016 - 2026 (US$ Million)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2026 (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
  • GCC Countries
  • Israel
  • Rest of Middle East

8. Competitive Landscape

  • Heat Map Analysis
  • Company Profiles
    • Ipsen
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
    • Bachem
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
    • Ferring Pharmaceuticals Pvt Ltd.
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
    • Chengdu Tiantaishan pharmaceutical Co., Ltd.
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
    • Tecnofarma
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
    • Dr. Reddy's Laboratories Ltd.
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
    • Teva Pharmaceutical Industries Ltd. (Actavis Specialty Pharmaceuticals Co.)
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
    • Debiopharm Group
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
    • Arbor Pharmaceuticals, LLC
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
  • Analyst Views

9. Section

  • References
  • Analyst Views
  • Research Methodology
  • About Us and Sales Contact
Back to Top
전화 문의
F A Q